Ligand Pharmaceuticals, Inc. (LGND)

201.90 -4.50 (-2.18%) USD  |  NASDAQ  |  Mar 06, 16:00
201.58 -0.32 (-0.16%) After-Hours: 20:00
More

Ligand Pharmaceuticals Income Tax Paid Supplemental Data (Quarterly)

Income Tax Paid Supplemental Data (Quarterly) Chart

View Income Tax Paid Supplemental Data (Quarterly) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Income Tax Paid Supplemental Data (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Income Tax Paid Supplemental Data (Quarterly) Range, Past 5 Years

View Income Tax Paid Supplemental Data (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Income Tax Paid Supplemental Data (Quarterly) Benchmarks

View Income Tax Paid Supplemental Data (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
Globus Medical, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade